Share the post "Godavari Drugs : Q4 2024 Financial Quarterly Report : YoY Sales Up 3.4 %, QoQ Down 10.37 %"
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 3.4 % in the past year, decrease in net sales/revenue by -10.37 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -31.25 %, Marginal increase in other income during this quarter, up by 120%.
- Profit over the Year and quarter: Significant improvement in profitability for Godavari Drugs Ltd.. Notable increase of 100 % in net profit Year to Year, Godavari Drugs Ltd.’s profitability increased by 118.02 % in this quarter.
- EPS over the Year and quarter: EPS increased by 99.44 % Year to Year. EPS increased by 117.9 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 37.37 Cr | Rs. 43.111 Cr | Rs. 38.64 Cr | -10.37 % | + 3.4 % |
| Expenses | Rs. 34.69 Cr | Rs. 39.59 Cr | Rs. 34.17 Cr | -13.69 % | -1.5 % |
| Operating Profit | Rs. 2.68 Cr | Rs. 3.52 Cr | Rs. 4.47 Cr | + 26.99 % | + 66.79 % |
| OPM % | 7.17 % | 8.16 % | 11.57 % | + 3.41 % | + 4.4 % |
| Other Income | Rs. 0.16 Cr | Rs. 0.05 Cr | Rs. 0.11 Cr | + 120 % | -31.25 % |
| Interest | Rs. 1.03 Cr | Rs. 1.28 Cr | Rs. 1.23 Cr | -3.91 % | + 19.42 % |
| Depreciation | Rs. 0.5 Cr | Rs. 0.5 Cr | Rs. 0.53 Cr | + 6 % | + 6 % |
| Profit before tax | Rs. 1.31 Cr | Rs. 1.79 Cr | Rs. 2.82 Cr | + 57.54 % | + 115.27 % |
| Tax % | 13.79 % | 29.87 % | 4.55 % | -25.32 % | -9.24 % |
| Net Profit | Rs. 1.33 Cr | Rs. 1.22 Cr | Rs. 2.66 Cr | + 118.03 % | + 100 % |
| EPS in Rs | Rs. 1.77 | Rs. 1.62 | Rs. 3.53 | + 117.9 % | + 99.44 % |
Today, we’re looking at Godavari Drugs Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 3.4 %. However, it did see a marginal slip of -10.37 % from the previous quarter. Expenses decreased slightly by -13.69 % quarter-on-quarter, aligning with the annual decline of -1.5 %. Operating profit, while up 66.79 % compared to last year, faced a quarter-on-quarter increase of 26.99 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 4.4 %, but an expansion of 3.41 % sequentially. Other income rose by 120 % compared to the last quarter, despite an annual decline of -31.25 %. Interest expenses dropped significantly by -3.91 % from the previous quarter, yet the year-over-year increase remains at a moderate 19.42 %. Depreciation costs climbed by 6 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 6 %. Profit before tax grew annually by 115.27 % but saw an increase from the preceding quarter by 57.54 %.
Tax expenses as a percentage of profits decreased slightly by -9.24 % compared to last year, with a more notable quarter-on-quarter decrease of -25.32 %. Net profit rose by 100 % year-on-year but experienced a 118.03 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 99.44 % but a quarterly rise of 117.9 %. In summary, Godavari Drugs Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 37.37 Cr | Rs. 43.111 Cr | Rs. 38.64 Cr | -10.37 % | + 3.4 % |
| Expenses | Rs. 34.69 Cr | Rs. 39.59 Cr | Rs. 34.17 Cr | -13.69 % | -1.5 % |
| Operating Profit | Rs. 2.68 Cr | Rs. 3.52 Cr | Rs. 4.47 Cr | + 26.99 % | + 66.79 % |
| Net Profit | Rs. 1.33 Cr | Rs. 1.22 Cr | Rs. 2.66 Cr | + 118.03 % | + 100 % |
| EPS in Rs | Rs. 1.77 | Rs. 1.62 | Rs. 3.53 | + 117.9 % | + 99.44 % |
In reviewing Godavari Drugs Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 3.4 % year-on-year growth, although there was a slight dip of -10.37 % from the previous quarter. Expenses decreased by -1.5 % compared to the previous year, with a decrease of -13.69 % quarter-on-quarter. Operating Profit surged by 66.79 % annually, and saw a 26.99 % increase from the last quarter.
Net Profit showed yearly increase of 100 %, and experienced a 118.03 % increase from the previous quarter. Earnings Per Share (EPS) rose by 99.44 % annually, however rose by 117.9 % compared to the last quarter. In essence, while Godavari Drugs Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
